Team discovers potential blood test for autistic patients

January 29, 2013

(Medical Xpress)—Results of a recent clinical study by researchers from Western and the University of Arkansas reveal the presence of a unique blood marker, which may further the understanding of possible gut linked environmental contributors to autism. The findings may also forecast potential blood tests for early screening to identify and potentially treat the condition, even before symptoms present.

The discovery, made by Dr. Derrick MacFabe of Western and Drs. Richard Frye and Stepan Melynk of Arkansas Children's Hospital Research Institute in Little Rock, Ark., found evidence of abnormal in a large subgroup of autistic children, which was consistent with previous biological breakthroughs made by MacFabe and his team over the past decade, further proving that these may arise, not only from , but from compounds produced by certain types of often found to be increased in the gut of persons with autism.

The paper, "Unique acyl-carnitine profiles are potential biomarkers of acquired mitochondrial disease in autism spectrum disorders," was recently published in the prestigious peer-reviewed open-access journal Translational Psychiatry.

Recent evidence suggests that biological abnormalities in many persons with autism spectrum disorders (ASD) are not restricted to the brain but can involve other body systems including the immune, energy generation, detoxification and digestive systems. These abnormalities may be due to impaired function of mitochondria, the energy producers of cells. ASD is a family of developmental conditions of impaired language and social development, as well as and restricted interests.

" affect up to one in 88 individuals," MacFabe said. "And the number appears to be increasing. Many have digestive and metabolic issues, but how they may relate to ASD behaviours and the increase of occurrence were unclear."

In this study of 213 children, the research team found 17 per cent of children with ASD had a unique pattern of blood markers of fat metabolism, called acyl-carnitines, as well as other evidence of abnormal cellular energy function, like reduced glutathione.

"This study suggests that autism in some patients can arise from alterations in mitochondrial function and fat metabolism following environmental exposure to propionic acid produced from ASD associated gut bacteria," MacFabe said.

Explore further: ADHD symptoms worsen quality of life for individuals with autism

More information:

Related Stories

Does the brain become unglued in autism?

December 11, 2012

A new study published in Biological Psychiatry suggests that autism is associated with reductions in the level of cellular adhesion molecules in the blood, where they play a role in immune function.

Recommended for you

New autism genes are revealed in largest-ever study

September 29, 2015

In the largest, most comprehensive genomic analysis of autism spectrum disorder (ASD) conducted to date, an international research team led by UC San Francisco scientists has identified 65 genes that play a role in the disorder, ...

Another study shows vaccines do not cause autism

September 29, 2015

(Medical Xpress)—A team of researchers with affiliations to several institutions in the U.S., has conducted a study at the University of Texas Southwestern Medical Center in Dallas, Texas, looking into the possibility of ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.